SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer

Bidard FC, Barrios C, Bianchini G, Brufsky AM, Chia S, Cortes J, Cristofanilli M, Curigliano G, Dawood S, Fasching P, Gerratana L, Giordano A, Ignatiadis M, Iwata H, Janni W, Lim E, Kalinsky K, Ma CX, Mayer EL, Medford AJ, Mouabbi JA, O’Shaughnessy J, Park YH, Pascual J, Razavi P, Sammons S, Sandoval JL, Sisca L, Tarantino P, Wander SA, Werutsky G, Turner NA (2026)

Publication Type: Journal article

Publication year: 2026

Journal

Book Volume: 12

Article Number: 80

Journal Issue: 1

DOI: 10.1038/s41523-026-00967-4

Authors with CRIS profile

Involved external institutions

British Columbia Cancer Agency Canada (CA) PANGAEA Oncology S.A. Spain (ES) Institut Curie France (FR) LACOG - Latin American Cooperative Oncology Group Brazil (BR) Ospedale San Raffaele (früher: Centro San Raffaele del Monte Tabor Foundation) Italy (IT) University of Pittsburgh Medical Center (UPMC) United States (USA) (US) Weill Cornell Medicine United States (USA) (US) Università degli studi di Milano Italy (IT) Centro di Riferimento Oncologico (CRO) Italy (IT) Dana-Farber Cancer Institute United States (USA) (US) Institut Jules Bordet Belgium (BE) Nagoya City University / 名古屋市立大学 Japan (JP) Universitätsklinikum Ulm Germany (DE) Garvan Institute of Medical Research Australia (AU) Emory University United States (USA) (US) Washington University in St. Louis United States (USA) (US) Harvard University United States (USA) (US) University of Texas MD Anderson Cancer Center United States (USA) (US) Baylor University Medical Center United States (USA) (US) Sungkyunkwan University (SKKU) Korea, Republic of (KR) Hospital Universitario Virgen de la Victoria Spain (ES) Memorial Sloan Kettering Cancer Center United States (USA) (US) Royal Marsden Hospital / The Royal Marsden NHS Foundation Trust United Kingdom (GB)

How to cite

APA:

Bidard, F.C., Barrios, C., Bianchini, G., Brufsky, A.M., Chia, S., Cortes, J.,... Turner, N.A. (2026). SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer. npj Breast Cancer, 12(1). https://doi.org/10.1038/s41523-026-00967-4

MLA:

Bidard, François Clement, et al. "SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer." npj Breast Cancer 12.1 (2026).

BibTeX: Download